Chiropractors in Baker City, OR Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Elkhorn Chiropractic Inc Chiropractor Medicare: Medicare Enrolled Practice Location: 2040 8th St, Baker City, OR 97814 Phone: 541-523-2495    Fax: 541-523-2495

Jarom Todd Hibbert, DC Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 2805 10th St, Baker City, OR 97814 Phone: 541-523-2495    Fax: 541-523-2495

Steven A Bachman Chiropractic Physician Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1290 Campbell St, Baker City, OR 97814 Phone: 541-523-6561    Fax: 541-523-6561

Lloyd E. Nelson, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 2899 10th St, Baker City, OR 97814 Phone: 541-523-6565

Dr. Steven Anthony Bachman, D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1290 Campbell St, Baker City, OR 97814 Phone: 541-523-6561    Fax: 541-523-6561

News Archive

Department of VA selects construction contractor for new Pittsburgh research building

The Department of Veterans Affairs has selected the construction contractor to build a research office building at the Pittsburgh VA Medical Center on University Drive.

Harbor BioSciences announces presentation of new data from Apoptone Phase I/IIa trial at ASCO Annual Meeting

Harbor BioSciences, Inc. today announced that new data from the Phase I/IIa clinical trial of the company's lead drug candidate Apoptone®, its anticancer drug candidate being developed for prostate cancer, will be presented as part of the Scientific Program in a General Poster Session at the American Society of Clinical Oncology (ASCO) Annual Meeting.

FDA clears Lorus' LOR-253 IND application for treatment of hematologic malignancies

Lorus Therapeutics Inc. today announced that the Food and Drug Administration completed its review and cleared the company's Investigational New Drug (IND) application of LOR-253 for the treatment of hematologic malignancies including acute myeloid leukemia (AML), high-risk myelodysplastic syndromes (MDS), lymphomas and multiple myeloma.

Researchers confirm link between contrast agent and abnormalities on brain MRI

For the first time, researchers have confirmed an association between a common magnetic resonance imaging (MRI) contrast agent and abnormalities on brain MRI, according to a new study published online in the journal Radiology. The new study raises the possibility that a toxic component of the contrast agent may remain in the body long after administration.

Read more Medical News

› Verified 9 days ago